| Medical and Health Sciences | Lifetime | 94 | DK 5 | 100.00 |
| Medical and Health Sciences | 2021-2025 | 231 | DK 4 | 99.96 |
| Public, Environmental and Occupational Health | Lifetime | 122 | DK 2 | 99.81 |
| Surgery | Lifetime | 208 | DK 6 | 99.82 |
| Epidemiology | Lifetime | 146 | DK 2 | 99.81 |
| Pediatrics, Perinatology and Child Health | Lifetime | 121 | DK 2 | 99.64 |
| Cardiology and Cardiovascular Medicine | Lifetime | 313 | DK 7 | 99.59 |
| Internal Medicine | Lifetime | 29 | DK 1 | 99.37 |
| Oncology | Lifetime | 352 | DK 3 | 99.41 |
| Pulmonary and Respiratory Medicine | Lifetime | 546 | DK 6 | 99.23 |
| General Health Professions | Lifetime | 992 | DK 5 | 98.85 |
| Clinical Pharmacology | Lifetime | 397 | DK 7 | 98.33 |
| Obstetrics and Gynecology | Lifetime | 239 | DK 4 | 98.46 |
| Genetics | Lifetime | 862 | DK 10 | 97.88 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 583 | DK 15 | 98.16 |
| Emergency Medicine | Lifetime | 316 | DK 10 | 97.32 |
| Pathology and Forensic Medicine | Lifetime | 593 | DK 14 | 97.38 |
| Psychiatry and Mental health | Lifetime | 968 | DK 9 | 95.60 |
| Rheumatology | Lifetime | 958 | DK 15 | 94.26 |
| Clinical Neurology | Lifetime | 942 | DK 12 | 93.80 |
| Hepatology | Lifetime | 514 | DK 6 | 94.41 |
| Hematology | Lifetime | 698 | DK 9 | 93.99 |
| Gastroenterology | Lifetime | 428 | DK 7 | 92.32 |
| Health | Lifetime | 945 | DK 5 | 91.76 |
| Microbiology | Lifetime | 476 | DK 16 | 89.59 |
| Dermatology | Lifetime | 843 | DK 26 | 89.73 |
| Reproductive Medicine | Lifetime | 918 | DK 11 | 86.02 |
| Orthopedics and Sports Medicine | Lifetime | 907 | DK 27 | 86.25 |
| Otolaryngology | Lifetime | 551 | DK 12 | 85.01 |
| Urology | Lifetime | 690 | DK 7 | 83.19 |
| Immunology and Allergy | Lifetime | 873 | DK 23 | 76.33 |
| Surgery | 2021-2025 | 173 | DK 6 | 98.96 |
| Epidemiology | 2021-2025 | 165 | DK 4 | 98.93 |
| Public, Environmental and Occupational Health | 2021-2025 | 222 | DK 3 | 98.09 |
| Pediatrics, Perinatology and Child Health | 2021-2025 | 147 | DK 1 | 97.63 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 286 | DK 7 | 97.53 |
| Internal Medicine | 2021-2025 | 30 | DK 1 | 96.70 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 232 | DK 7 | 95.62 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 453 | DK 3 | 95.16 |
| Clinical Psychology | 2021-2025 | 579 | DK 3 | 94.31 |
| Oncology | 2021-2025 | 504 | DK 5 | 93.28 |
| General Health Professions | 2021-2025 | 917 | DK 4 | 92.36 |
| Psychiatry and Mental health | 2021-2025 | 296 | DK 4 | 92.62 |
| Health | 2021-2025 | 310 | DK 1 | 91.10 |
| Clinical Pharmacology | 2021-2025 | 326 | DK 5 | 86.30 |
| Genetics | 2021-2025 | 524 | DK 8 | 85.19 |
| Medical Physiology | 2021-2025 | 911 | DK 24 | 84.67 |
| Clinical Neurology | 2021-2025 | 431 | DK 4 | 84.89 |
| Obstetrics and Gynecology | 2021-2025 | 330 | DK 9 | 82.26 |
| Cancer Research | 2021-2025 | 477 | DK 6 | 56.29 |
| Pregnancy and Medication Impact | Lifetime | 3 | DK 1 | 99.85 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 19 | DK 1 | 99.87 |
| Birth, Development, and Health | Lifetime | 86 | DK 5 | 99.58 |
| Pregnancy and preeclampsia studies | Lifetime | 75 | DK 1 | 99.55 |
| Chronic Disease Management Strategies | Lifetime | 44 | DK 1 | 99.36 |
| Inflammatory mediators and NSAID effects | Lifetime | 69 | DK 1 | 99.28 |
| Cancer, Stress, Anesthesia, and Immune Response | Lifetime | 25 | DK 2 | 98.95 |
| Cancer Diagnosis and Treatment | Lifetime | 110 | DK 2 | 99.15 |
| Cardiac, Anesthesia and Surgical Outcomes | Lifetime | 305 | DK 9 | 99.26 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 192 | DK 5 | 99.44 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 103 | DK 5 | 99.46 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 269 | DK 4 | 99.18 |
| Liver Disease Diagnosis and Treatment | Lifetime | 604 | DK 9 | 99.21 |
| Colorectal Cancer Screening and Detection | Lifetime | 185 | DK 3 | 99.12 |
| Folate and B Vitamins Research | Lifetime | 160 | DK 3 | 98.16 |
| Healthcare cost, quality, practices | Lifetime | 81 | DK 1 | 98.48 |
| Gastric Cancer Management and Outcomes | Lifetime | 599 | DK 4 | 98.74 |
| Pneumonia and Respiratory Infections | Lifetime | 341 | DK 3 | 98.78 |
| Acute Myocardial Infarction Research | Lifetime | 333 | DK 8 | 98.92 |
| Cancer, Lipids, and Metabolism | Lifetime | 427 | DK 6 | 98.37 |
| Blood Coagulation and Thrombosis Mechanisms | Lifetime | 249 | DK 3 | 98.16 |
| Liver Disease and Transplantation | Lifetime | 572 | DK 11 | 98.54 |
| Inflammatory Bowel Disease | Lifetime | 367 | DK 9 | 98.35 |
| Cancer Risks and Factors | Lifetime | 207 | DK 5 | 98.42 |
| Potassium and Related Disorders | Lifetime | 85 | DK 1 | 98.04 |
| Gestational Diabetes Research and Management | Lifetime | 303 | DK 9 | 98.07 |
| Genetic factors in colorectal cancer | Lifetime | 641 | DK 4 | 97.83 |
| Multiple and Secondary Primary Cancers | Lifetime | 263 | DK 7 | 97.27 |
| Helicobacter pylori-related gastroenterology studies | Lifetime | 721 | DK 9 | 97.70 |
| Cardiac Health and Mental Health | Lifetime | 353 | DK 6 | 97.56 |
| Lipoproteins and Cardiovascular Health | Lifetime | 523 | DK 9 | 97.86 |
| Bone health and treatments | Lifetime | 514 | DK 13 | 97.66 |
| Drug-Induced Adverse Reactions | Lifetime | 205 | DK 6 | 96.91 |
| Estrogen and related hormone effects | Lifetime | 744 | DK 3 | 97.50 |
| Global Cancer Incidence and Screening | Lifetime | 541 | DK 12 | 97.52 |
| Bacterial Infections and Vaccines | Lifetime | 395 | DK 3 | 97.03 |
| Emergency and Acute Care Studies | Lifetime | 648 | DK 6 | 96.88 |
| Medical Coding and Health Information | Lifetime | 53 | DK 1 | 95.97 |
| Pancreatitis Pathology and Treatment | Lifetime | 776 | DK 4 | 97.01 |
| Pharmaceutical studies and practices | Lifetime | 497 | DK 9 | 96.61 |
| Child and Adolescent Health | Lifetime | 533 | DK 4 | 95.66 |
| Microscopic Colitis | Lifetime | 586 | DK 13 | 97.12 |
| Gastroesophageal reflux and treatments | Lifetime | 706 | DK 11 | 96.62 |
| Gastrointestinal Bleeding Diagnosis and Treatment | Lifetime | 282 | DK 3 | 95.74 |
| Alcohol Consumption and Health Effects | Lifetime | 687 | DK 11 | 95.69 |
| Central Venous Catheters and Hemodialysis | Lifetime | 778 | DK 3 | 95.34 |
| Healthcare Systems and Technology | Lifetime | 318 | DK 4 | 94.99 |
| Hematological disorders and diagnostics | Lifetime | 522 | DK 5 | 93.64 |
| Antibiotic Use and Resistance | Lifetime | 789 | DK 5 | 95.59 |
| Economic and Financial Impacts of Cancer | Lifetime | 605 | DK 6 | 94.29 |
| Clinical practice guidelines implementation | Lifetime | 677 | DK 15 | 93.85 |
| Cardiovascular Issues in Pregnancy | Lifetime | 834 | DK 6 | 94.38 |
| Diagnosis and Treatment of Venous Diseases | Lifetime | 492 | DK 5 | 94.15 |
| Diverticular Disease and Complications | Lifetime | 827 | DK 14 | 94.06 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 348 | DK 19 | 93.73 |
| Pharmacovigilance and Adverse Drug Reactions | Lifetime | 264 | DK 6 | 92.95 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 553 | DK 8 | 91.17 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | Lifetime | 787 | DK 24 | 92.25 |
| Management of metastatic bone disease | Lifetime | 900 | DK 11 | 91.94 |
| Intestinal Malrotation and Obstruction Disorders | Lifetime | 743 | DK 3 | 90.97 |
| Neurological Complications and Syndromes | Lifetime | 944 | DK 11 | 87.87 |
| Acne and Rosacea Treatments and Effects | Lifetime | 870 | DK 15 | 85.82 |
| Birth, Development, and Health | 2021-2025 | 51 | DK 1 | 98.53 |
| Venous Thromboembolism Diagnosis and Management | 2021-2025 | 97 | DK 1 | 98.80 |
| Chronic Disease Management Strategies | 2021-2025 | 123 | DK 3 | 95.82 |
| Colorectal Cancer Screening and Detection | 2021-2025 | 281 | DK 4 | 95.38 |
| Inflammatory mediators and NSAID effects | 2021-2025 | 49 | DK 4 | 92.82 |
| Gastric Cancer Management and Outcomes | 2021-2025 | 915 | DK 5 | 93.86 |
| Diabetes Treatment and Management | 2021-2025 | 688 | DK 21 | 93.12 |
| Cardiac Health and Mental Health | 2021-2025 | 443 | DK 16 | 88.88 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 856 | DK 1 | 89.09 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 723 | DK 19 | 86.88 |
| Antiplatelet Therapy and Cardiovascular Diseases | 2021-2025 | 654 | DK 16 | 86.88 |
| Diagnosis and Treatment of Venous Diseases | 2021-2025 | 257 | DK 2 | 86.15 |
| Mental Health Treatment and Access | 2021-2025 | 821 | DK 16 | 86.69 |
| Suicide and Self-Harm Studies | 2021-2025 | 688 | DK 3 | 86.74 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 968 | DK 23 | 85.21 |
| Diverticular Disease and Complications | 2021-2025 | 528 | DK 21 | 79.53 |
| Neurological Complications and Syndromes | 2021-2025 | 225 | DK 7 | 76.89 |
| Chemotherapy-induced cardiotoxicity and mitigation | 2021-2025 | 541 | DK 1 | 76.96 |
| Cerebral Venous Sinus Thrombosis | 2021-2025 | 613 | DK 14 | 74.15 |
| Migraine and Headache Studies | 2021-2025 | 779 | DK 45 | 77.60 |
| Cancer Risks and Factors | 2021-2025 | 950 | DK 21 | 73.93 |
| Healthcare cost, quality, practices | 2021-2025 | 802 | DK 7 | 72.12 |
| Neonatal and Maternal Infections | 2021-2025 | 500 | DK 10 | 69.86 |
| Acne and Rosacea Treatments and Effects | 2021-2025 | 488 | DK 10 | 70.52 |
| Neutropenia and Cancer Infections | 2021-2025 | 946 | DK 10 | 67.40 |
| Neurological and metabolic disorders | 2021-2025 | 265 | DK 5 | 67.55 |
| Cancer, Stress, Anesthesia, and Immune Response | 2021-2025 | 751 | DK 4 | 61.31 |